161 related articles for article (PubMed ID: 8149355)
1. Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance.
Hitri A; Hurd YL; Wyatt RJ; Deutsch SI
Clin Neuropharmacol; 1994 Feb; 17(1):1-22. PubMed ID: 8149355
[TBL] [Abstract][Full Text] [Related]
2. [The dopamine transporter: characterization and physiopathologic implications].
Thibaut F; Vaugeois JM; Petit M
Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.
Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME
J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909).
Zhang Y; Rothman RB; Dersch CM; de Costa BR; Jacobson AE; Rice KC
J Med Chem; 2000 Dec; 43(25):4840-9. PubMed ID: 11123994
[TBL] [Abstract][Full Text] [Related]
6. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
Matecka D; Rothman RB; Radesca L; de Costa BR; Dersch CM; Partilla JS; Pert A; Glowa JR; Wojnicki FH; Rice KC
J Med Chem; 1996 Nov; 39(24):4704-16. PubMed ID: 8941383
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration.
Storch A; Ludolph AC; Schwarz J
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1267-86. PubMed ID: 15480838
[TBL] [Abstract][Full Text] [Related]
10. Oxygenated analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents.
Lewis DB; Matecka D; Zhang Y; Hsin LW; Dersch CM; Stafford D; Glowa JR; Rothman RB; Rice KC
J Med Chem; 1999 Dec; 42(24):5029-42. PubMed ID: 10585212
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transport function is elevated in cocaine users.
Mash DC; Pablo J; Ouyang Q; Hearn WL; Izenwasser S
J Neurochem; 2002 Apr; 81(2):292-300. PubMed ID: 12064476
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent.
Mayfield RD; Zahniser NR
Mol Pharmacol; 2001 Jan; 59(1):113-21. PubMed ID: 11125031
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporters participate in the physiological regulation of prolactin.
Demaria JE; Nagy GM; Lerant AA; Fekete MI; Levenson CW; Freeman ME
Endocrinology; 2000 Jan; 141(1):366-74. PubMed ID: 10614659
[TBL] [Abstract][Full Text] [Related]
17. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims.
Staley JK; Hearn WL; Ruttenber AJ; Wetli CV; Mash DC
J Pharmacol Exp Ther; 1994 Dec; 271(3):1678-85. PubMed ID: 7996484
[TBL] [Abstract][Full Text] [Related]
18. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
Rothman RB; Dersch CM; Carroll FI; Ananthan S
Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
[TBL] [Abstract][Full Text] [Related]
19. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
[TBL] [Abstract][Full Text] [Related]
20. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.
Wilson JM; Levey AI; Bergeron C; Kalasinsky K; Ang L; Peretti F; Adams VI; Smialek J; Anderson WR; Shannak K; Deck J; Niznik HB; Kish SJ
Ann Neurol; 1996 Sep; 40(3):428-39. PubMed ID: 8797532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
